InvestorsHub Logo
Followers 62
Posts 3990
Boards Moderated 0
Alias Born 05/25/2021

Re: herbied47 post# 339

Wednesday, 07/19/2023 5:59:25 PM

Wednesday, July 19, 2023 5:59:25 PM

Post# of 550
I don't think you got the facts correct.

Clearly TTF + SOC delivered the results even worse than SOC. Likewise for the case of TTF + ICI and TTF + DTX except the case PD-L1 expression less than 1%.

The trial was a total failure!

https://www.novocure.com/lunar-phase-3-clinical-trial-demonstrates-statistically-significant-and-clinically-meaningful-extension-in-overall-survival-for-patients-with-metastatic-non-small-cell-lung-cancer-after-platinum-based/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVCR News